Practical Diabetology is a professional journal providing busy physicians with straightforward, practical information to enhance the care and treatment they give their diabetes patients. Articles concern all aspects of diabetes and its complications and are designed to be quickly read, easily understood, and readily incorporated into daily practice.
To browse our archive or search for articles by subject, see the archive or subject index page. Two Minutes With Diabetes offers brief and instructive case studies on common problems arising in diabetes care.
Volume 34, Number 4 (November/December)
Exploring Culture and Cuisine to Provide Culturally: Appropriate Diabetes Education for the Latino Population (pages 7–14)
Britt Rotberg, MS, RDN, LD, CDE, BC-ADM, Department of Medicine, Emory University, Atlanta; Yasmine Junqueira, RDN, LD, Department of Medicine, Emory University, Atlanta; Ashley Mayer, MS, RDN, LD, Grady Memorial Hospital, Atlanta
The Hispanic Community Health Study/Study of Latinos found the prevalence of Type 2 diabetes among Latino groups is about 16.9%, compared to 10.2% for non-Hispanic whites. With this in mind, health-care providers need to be culturally aware to properly care for Latinos with diabetes. A key player in the Latin American culture is food; meals provide a time to gather and socialize with family and friends. Analyzing the composition of staple meals in the Latino diet can provide much insight into diabetes management and control.
Diabetes in specific populations — Latino
Jennifer Elliott, PharmD, CDE; Sara (Mandy) Reece, PharmD, CDE, BC-ADM
In 1977, recombinant human insulin technology transformed insulin therapy. Rapid acting analogues and basal insulin analogues followed. Initially, all insulins were U-100 concentration—1 ml contains 100 units of insulin. This article outlines the newer additions to today’s insulin options, including U-500, U-300 and U-200 concentrations.
Drug treatment — Insulin
This column highlights recent clinical trial data and landmark clinical trials to provide readers with relevant information and links for obtaining clinical trial data and articles to facilitate discussion with patients and other providers. It features the results of the Centers for Medicare & Medicaid’s (CMS) trial of the Competitive Bidding Program (CBP) on patient access to diabetes supplies in nine test sites; and the results of EMPA-REG OUTCOME, a phase III, multicenter, international, randomized, parallel-group, double-blind cardiovascular safety study of BI 10773 (10mg and 25mg administered orally once daily) compared to usual care in Type 2 diabetes mellitus patients with increased cardiovascular risk.
I have seen people in their 70s, and even in their 90s, diagnosed with autoimmune T1D. Clearly, T1D no longer is “juvenile onset diabetes.” In fact, up to 30% of all T1D is diagnosed above the age of 18. It is difficult to determine exactly what percentage of patients with T1D are diagnosed as adults, because most databases assume diabetes diagnosed over age 18 is Type 2.
Diabetes in specific populations — Geriatric